Antibody conjugation is essential for targeted lipid nanoparticle (LNP) delivery, but here we show that click-chemistry produces artifacts that confound accurate measurement of covalent antibody-LNP bonding. We demonstrate that hydrophobic interactions between the most common click alkyne linker, dibenzocyclooctyne (DBCO), and the inherently hydrophobic LNP surface drive extensive nonspecific antibody physisorption, even in the absence of LNP azide groups. This physisorption yields artificially high apparent conjugation efficiencies measured by chromatographic methods. In contrast, less hydrophobic liposomes exhibit azide-dependent conjugation, highlighting a consequence of nanoparticle surface chemistry. Plasma incubation rapidly displaces physisorbed antibodies from LNPs, confirming their weak, noncovalent association, whereas covalently bound antibodies remain attached and enable effective in vivo targeting. Substituting DBCO with the less hydrophobic bicyclononyne (BCN) also reduces nonspecific associations. Our findings reveal hydrophobicity as a hidden variable in antibody-LNP conjugation and establish new standards for quantitative and reproducible measurement of targeted LNPs.
Decoupling Physisorption from Chemisorption in Clickable Lipid Nanoparticles
Abstract
Metrics
Details
- Title
- Decoupling Physisorption from Chemisorption in Clickable Lipid Nanoparticles
- Creators
- Taylor V. Brysgel - California University of PennsylvaniaElizabeth D. Hood - California University of PennsylvaniaAleksa Milosavljevic - California University of PennsylvaniaNicolas Marzolini - California University of PennsylvaniaMarco E. Zamora - California University of PennsylvaniaJichuan Wu - California University of PennsylvaniaVladimir V. Shuvaev - California University of PennsylvaniaTea Shuvaeva - California University of PennsylvaniaMichael Kegel - Kaiser PermanenteJenna Muscat-Rivera - Kaiser PermanenteDrew Weissman - Kaiser PermanenteJilian R. Melamed - Kaiser PermanenteJacob W. Myerson - California University of PennsylvaniaJacob S. Brenner - California University of PennsylvaniaVladimir R. Muzykantov - California University of PennsylvaniaJia Nong - California University of Pennsylvania
- Publication Details
- ACS Nanoscience Au
- Publisher
- AMER CHEMICAL SOC; WASHINGTON
- Number of pages
- 9
- Grant note
- American Society of Gene and Cell Therapy: NA National Heart, Lung, and Blood Institute: R01-HL-153510 Division of Biological Infrastructure: DBI-2400135 Perelman School of Medicine, University of Pennsylvania: NA
Research reported in this publication was supported by the National Science Foundation under Cooperative Agreement DBI - 2400135 (to T.V.B. and V.R.M.), the National Institutes of Health R01-HL-153510 (J.S.B.), -HL-160694 (J.S.B.), -HL-164594, (J.S.B.), -HL-157189 (J.S.B.), -HL-155106 (V.R.M.), the Institute for RNA Innovation of the Perelman School of Medicine at the University of Pennsylvania (J.N.), and the American Society of Gene and Cell Therapy Career Development Award (J.N.). The flow cytometry data for this manuscript were generated in the Penn Cytomics and Cell Sorting Shared Resource Laboratory at the University of Pennsylvania (RRID:SCR_022376). Penn Cytomics is partially supported by the Abramson Cancer Center NCI Grant (P30 016520). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Figures - and the Table of Contents (TOC)/Abstract Graphic contain elements created with BioRender (Brenner, J., 2026; https://BioRender.com/d3dsre0).
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- School of Biomedical Engineering, Science, and Health Systems
- Web of Science ID
- WOS:001696761000001
- Other Identifier
- 991022166402004721